Boulder, CO, United States of America

Matthew A Gingrich


Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Westminster, CO (US) (2000)
  • Boulder, CO (US) (2003)

Company Filing History:


Years Active: 2000-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Matthew A. Gingrich

Introduction

Matthew A. Gingrich is an accomplished inventor based in Boulder, Colorado. He has made significant contributions to the field of medical technology, particularly in assessing blood flow and anesthetic gas monitoring. With a total of 2 patents, his work has the potential to enhance medical practices and improve patient outcomes.

Latest Patents

Matthew's latest patents include a method and system for assessing collateral blood flow to a tissue region of interest. This invention provides a reliable way to measure blood flow, which is crucial for medical personnel in evaluating tissue health. The method involves obtaining pulsatility measurements to generate a collateral flow value, offering an objective measure for assessing blood flow. His second patent focuses on agent identification for anesthetic gas monitors using minimum alveolar concentration (MAC). This apparatus and method allow for the identification of primary and secondary anesthetic agents based on their MAC percentages, ensuring accurate monitoring during medical procedures.

Career Highlights

Matthew A. Gingrich is currently employed at Datex-Ohmeda, Inc., where he continues to innovate in the medical technology sector. His work has been instrumental in developing solutions that address critical challenges in patient care.

Collaborations

Matthew collaborates with various professionals in his field, including his coworker Jonas Alexander Pologe. Their combined expertise contributes to the advancement of medical technologies and innovations.

Conclusion

Matthew A. Gingrich's contributions to medical technology through his patents demonstrate his commitment to improving healthcare practices. His innovative methods for assessing blood flow and monitoring anesthetic agents are valuable assets to the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…